Stryker (NYSE: SYK) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 12.63%. Currently, Stryker has a market capitalization of ...
The Synchfix EVT device builds on the previous Synchfix platform and introduces design improvements to minimise procedural ...
If you are wondering whether Stryker’s current share price still offers value, or if most of the opportunity is already reflected in the market, you are not alone. With the stock last closing at ...
Think Surgical today announced the first completed cases using the TMINI miniature robotic system with the Stryker Triathlon knee system.
Stryker Corporation (NYSE:SYK) is included among the 13 Best Performing Long Term Stocks to Invest in. On February 24, UBS ...
Stryker (NYSE: SYK) announced today that it launched the Synchfix EVT next-generation syndesmotic fixation device.
Whether through pressure injury prevention, fall prevention, infection prevention or safe patient handling initiatives, Stryker’s mission is to do everything possible to provide the optimal experience ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $426.14, along ...
SYK launches Synchfix EVT, a next-gen ankle fixation system designed to streamline surgery and expand reach into adolescent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results